Home › Trial NCT01594723
A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
- Trial IDNCT01594723
- StatusActive Not Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorEli Lilly and Company
- Enrollment110
- Start date2012-05-22
- ConditionsNeoplasms, Hematologic
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.